Ticker

6/recent/ticker-posts

GSEB SSC NEW PAPER STYLE ALL SUBJECT - 2021

 GSEB SSC NEW PAPER STYLE ALL SUBJECT - 2021





According to the popular Tipster digital chat station, the OnePlus 9 series will not include the usual telephoto lens and periscope lens. It limits the phone's zooming capability, for now the company can only explain why it chose to drop the OnePlus' Periscope lens, which was seen on many phones this year. Tipster also did not say whether this is a supply chain issue or something else but claims that next year fewer phones will integrate camera lens technology into their phones.
The OnePlus 9 series could come with a Leica camera lens, according to a report. If this is true it could mean that the upcoming phone series could have a significant improvement in the case of photography compared to its previous generation phones.
The Vanilla OnePlus 9 model can come with a triple rear camera setup with a 50MP primary camera. It allegedly includes a 20MP ultra-wide angle cine camera with f / 1.8 aperture and a 12MP telephoto camera with autofocus and f / 3.4 lens. The Pro model can come with a quad rear camera setup with IP68 rating.

There are currently 232 corona vaccines in the world. According to the WHO vaccine landscape, 172 of these vaccines are in pre-clinical trials. This means that the vaccine is currently being tested in labs. While 60 vaccines are in clinical trials. Clinical trials usually take many years. But so far 9 vaccines have received emergency approval in the world which considers corona as emergency.

Currently, 4 vaccines from China, 2 from Russia, 2 from USA and 1 from Britain have received emergency approval.
The newest vaccine is Covishield of Oxford / AstraZeneca, which was given emergency approval by Britain on December 30.
Vaccination has started in about 16 countries.
7 vaccines in the world are still in phase-3 trials and have not received approval anywhere.
20 vaccines are in Phase-2 trials and 22 vaccines are in Phase-2 human trials.
Pfizer's vaccine has been approved in at least 12 countries. Pfizer has sought emergency approval in India.
In India, the Serum Institute of India (SII) and Bharat Biotech have also sought emergency approval for their respective vaccines. The expert committee has sought information from these companies.
The Serum Institute of India and Bharat Biotech in India have also sought emergency approval for their respective vaccines. The expert committee has sought more information from these companies.
The results of trials of 4 vaccines came, four got approval
1. Oxford University / AstraZeneca
Oxford University and AstraZeneca have jointly developed a vaccine (Covishield). It is 90 percent effective in early results. The Serum Institute of India, the world's leading vaccine production company, had on December 7 sought emergency approval of Kovishield in India. On this, the Subject Expert Committee of India has asked Kovishield to provide more data. After getting approval in Britain on December 30, the possibility of getting approval in India has also increased.

MATHS


SCIENCE


ENGLISH


SOCIAL SCIENCE


GUJARATI


The joint corona vaccine of American pharma company Pfizer and German company Bioentech has proved to be 95% effective in the Phase-3 trial. The vaccine was given emergency approval on December 2 in the UK. Since then, 16 countries have approved it. The process of vaccinating priority groups has already begun in many countries.

Post a Comment

0 Comments